User menu

Managing Haemophilia for Life: 5th Haemophilia Global Summit.

Bibliographic reference Hermans, Cédric ; Dolan, Gerry ; Jennings, Ian ; Windyga, Jerzy ; Lobet, Sébastien ; et. al. Managing Haemophilia for Life: 5th Haemophilia Global Summit.. In: European Journal of Haematology, Vol. 95, no. 78, p. 1-25 (2015)
Permanent URL
  1. Srivastava A., Brewer A. K., Mauser-Bunschoten E. P., Key N. S., Kitchen S., Llinas A., Ludlam C. A., Mahlangu J. N., Mulder K., Poon M. C., Street A., , Guidelines for the management of hemophilia, 10.1111/j.1365-2516.2012.02909.x
  2. van den Berg H. M., Fischer K., Mauser-Bunschoten E. P., Beek F. J. A., Roosendaal G., van der Bom J. G., Nieuwenhuis H. K., Long-term outcome of individualized prophylactic treatment of children with severe haemophilia, 10.1046/j.1365-2141.2001.02580.x
  3. COLLINS P. W., BLANCHETTE V. S., FISCHER K., BJÖRKMAN S., OH M., FRITSCH S., SCHROTH P., SPOTTS G., ASTERMARK J., EWENSTEIN B., , Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A, 10.1111/j.1538-7836.2008.03270.x
  4. Manco-Johnson Marilyn J., Abshire Thomas C., Shapiro Amy D., Riske Brenda, Hacker Michele R., Kilcoyne Ray, Ingram J. David, Manco-Johnson Michael L., Funk Sharon, Jacobson Linda, Valentino Leonard A., Hoots W. Keith, Buchanan George R., DiMichele Donna, Recht Michael, Brown Deborah, Leissinger Cindy, Bleak Shirley, Cohen Alan, Mathew Prasad, Matsunaga Alison, Medeiros Desiree, Nugent Diane, Thomas Gregory A., Thompson Alexis A., McRedmond Kevin, Soucie J. Michael, Austin Harlan, Evatt Bruce L., Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia, 10.1056/nejmoa067659
  5. Bjorkman S., Prophylactic dosing of factor VIII and factor IX from a clinical pharmacokinetic perspective, 10.1046/j.1365-2516.9.s1.4.x
  6. Ahnstrom J., Berntorp E., Lindvall K., Bjorkman S., A 6-year follow-up of dosing, coagulation factor levels and bleedings in relation to joint status in the prophylactic treatment of haemophilia, 10.1111/j.1365-2516.2004.01036.x
  7. COLLINS P. W., BJÖRKMAN S., FISCHER K., BLANCHETTE V., OH M., SCHROTH P., FRITSCH S., CASEY K., SPOTTS G., EWENSTEIN B. M., Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens, 10.1111/j.1538-7836.2009.03703.x
  8. COLLINS P. W., Personalized prophylaxis : PERSONALIZED PROPHYLAXIS, 10.1111/j.1365-2516.2012.02838.x
  9. BJÖRKMAN S., BLANCHETTE V. S., FISCHER K., OH M., SPOTTS G., SCHROTH P., FRITSCH S., PATRONE L., EWENSTEIN B. M., COLLINS P. W., , Comparative pharmacokinetics of plasma- and albumin-free recombinant factor VIII in children and adults: the influence of blood sampling schedule on observed age-related differences and implications for dose tailoring, 10.1111/j.1538-7836.2010.03757.x
  10. COLLINS P. W., FISCHER K., MORFINI M., BLANCHETTE V. S., BJÖRKMAN S., , Implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophilia : PHARMACOKINETICS AND PROPHYLAXIS, 10.1111/j.1365-2516.2010.02370.x
  11. BLANCHETTE V. S., SHAPIRO A. D., LIESNER R. J., HERNNDEZ NAVARRO F., WARRIER I., SCHROTH P. C., SPOTTS G., EWENSTEIN B. M., , Plasma and albumin-free recombinant factorVIII: pharmacokinetics, efficacy and safety in previously treated pediatric patients, 10.1111/j.1538-7836.2008.03032.x
  12. Vyas S., Enockson C., Hernandez L., Valentino L. A., Towards personalizing haemophilia care: using the Haemophilia Severity Score to assess 178 patients in a single institution, 10.1111/hae.12227
  13. Lee M et al Scientific and Standardization Committee communication 2001
  14. Björkman, Haemophilia, 16, 597 (2010)
  15. JENNINGS I., KITCHEN D. P., WOODS T. A. L., KITCHEN S., WALKER I. D., PRESTON F. E., Laboratory performance in the World Federation of Hemophilia EQA programme, 2003-2008, 10.1111/j.1365-2516.2008.01933.x
  16. Björkman S., Pharmacokinetics of plasma-derived and recombinant factor IX - implications for prophylaxis and on-demand therapy, 10.1111/hae.12216
  17. Berntorp E., Pharmacokinetics of plasma-derived and recombinant factor IX: using population pharmacokinetics with sparse sampling data needs further study, 10.1111/hae.12277
  18. Feng D., Stafford K. A., Broze G. J., Stafford D. W., Evidence of clinically significant extravascular stores of factor IX, 10.1111/jth.12421
  19. Stern David M., Knitter Glen, Kisiel Walt, Nawroth Peter P., In vivo evidence of intravascular binding sites for coagulation factor IX, 10.1111/j.1365-2141.1987.tb01303.x
  20. CHMP guideline on the clinical investigation of recombinant and human plasma-derived factor IX products 2011
  21. Mikaelsson M, Oswaldsson U, Jankowski M.A, Measurement of factor VIII activity of B-domain deleted recombinant factor VIII, 10.1016/s0037-1963(01)90104-0
  22. Barrowcliffe Trevor W., Raut Sanjeev, Sands Dawn, Hubbard Anthony R., Coagulation and Chromogenic Assays of Factor VIII Activity: General Aspects, Standardization, and Recommendations, 10.1055/s-2002-32658
  23. Barrowcliffe T. W., Standardization of FVIII & FIX assays, 10.1046/j.1365-2516.2003.00773.x
  24. Collins Peter W., Chalmers Elizabeth, Hart Daniel P., Liesner Ri, Rangarajan Savita, Talks Kate, Williams Mike, Hay Charles R., Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition), 10.1111/bjh.12091
  25. Preston F. E., Kitchen S., Jennings I., Woods T. A. L., Makris M., SSC/ISTH classification of hemophilia A: can hemophilia center laboratories achieve the new criteria?, 10.1046/j.1538-7836.2003.00447.x
  26. Kitchen and Preston in Quality in Laboratory Hemostasis and Thrombosis 2nd edn London Wiley Blackwell 2013
  27. Mackie I., Cooper P., Lawrie A., Kitchen S., Gray E., Laffan M., , Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis, 10.1111/ijlh.12004
  28. Mikaelsson Marianne, Oswaldsson Ulla, Assaying the Circulating Factor VIII Activity in Hemophilia A Patients Treated with Recombinant Factor VIII Products, 10.1055/s-2002-32659
  29. Sommer J. M., Moore N., McGuffie-Valentine B., Bardan S., Buyue Y., Kamphaus G. D., Konkle B. A., Pierce G. F., Comparative field study evaluating the activity of recombinant factor VIII Fc fusion protein in plasma samples at clinical haemostasis laboratories, 10.1111/hae.12296
  30. Pouplard, Haemophilia, 17, e958 (2011)
  31. Caron C., Dautzenberg M-D., Delahousse B., Droulle C., Pouzol P., Dubanchet A., Rothschild C., A blinded in vitro study with RefactoR mock plasma samples: similar FVIII results between the chromogenic assay and a one-stage assay when using a higher cephalin dilution, 10.1046/j.1365-2516.2002.00666.x
  32. Lee C. A., Kessler C. M., Varon D., Martinowitz U., Heim M., MIKAELSSON M., OSWALDSSON U., SANDBERG H., Influence of phospholipids on the assessment of factor VIII activity, 10.1046/j.1365-2516.1998.440646.x
  33. Kitchen S., Gray E., Mertens K., Monitoring of modified factor VIII and IX products, 10.1111/hae.12423
  34. Hubbard A. R., Dodt J., Lee T., Mertens K., Seitz R., Srivastava A., Weinstein M., , Recommendations on the potency labelling of factor VIII and factor IX concentrates, 10.1111/jth.12167
  35. Gu J-M., Ramsey P., Evans V., Tang L., Apeler H., Leong L., Murphy J. E., Laux V., Myles T., Evaluation of the activated partial thromboplastin time assay for clinical monitoring of PEGylated recombinant factor VIII (BAY 94-9027) for haemophilia A, 10.1111/hae.12374
  36. Powell J. S., Josephson N. C., Quon D., Ragni M. V., Cheng G., Li E., Jiang H., Li L., Dumont J. A., Goyal J., Zhang X., Sommer J., McCue J., Barbetti M., Luk A., Pierce G. F., Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients, 10.1182/blood-2011-09-382846
  37. Young G., Sorensen B., Dargaud Y., Negrier C., Brummel-Ziedins K., Key N. S., Thrombin generation and whole blood viscoelastic assays in the management of hemophilia: current state of art and future perspectives, 10.1182/blood-2012-08-378935
  38. GISSEL M., WHELIHAN M. F., FERRIS L. A., MANN K. G., RIVARD G. E., BRUMMEL-ZIEDINS K. E., The influence of prophylactic factor VIII in severe haemophilia A : PROPHYLACTIC FACTOR VIII IN SEVERE HAEMOPHILIA A, 10.1111/j.1365-2516.2011.02638.x
  39. SANTAGOSTINO E., MANCUSO M. E., TRIPODI A., CHANTARANGKUL V., CLERICI M., GARAGIOLA I., MANNUCCI P. M., Severe hemophilia with mild bleeding phenotype: molecular characterization and global coagulation profile, 10.1111/j.1538-7836.2010.03767.x
  40. FELDMAN B. M., PAI M., RIVARD G. E., ISRAELS S., POON M.-C., DEMERS C., ROBINSON S., LUKE K.-H., WU J. K. M., GILL K., LILLICRAP D., BABYN P., MCLIMONT M., BLANCHETTE V. S., , Tailored prophylaxis in severe hemophilia A: interim results from the first 5 years of the Canadian Hemophilia Primary Prophylaxis Study, 10.1111/j.1538-7836.2006.01953.x
  41. Fischer K., Konkle B., Broderick C., Kessler C. M., Prophylaxis in real life scenarios, 10.1111/hae.12425
  42. Fischer K., Hermans C., , The European Principles of Haemophilia Care: a pilot investigation of adherence to the principles in Europe, 10.1111/j.1365-2516.2012.02928.x
  43. STONEBRAKER J. S., BROOKER M., AMAND R. E., FARRUGIA A., SRIVASTAVA A., A study of reported factor VIII use around the world, 10.1111/j.1365-2516.2009.02131.x
  44. WU R., LUKE K.-H., POON M.-C., WU X., ZHANG N., ZHAO L., SU Y., ZHANG J., Low dose secondary prophylaxis reduces joint bleeding in severe and moderate haemophilic children: a pilot study in China : LOW DOSE SECONDARY PROPHYLAXIS IN HAEMOPHILIA, 10.1111/j.1365-2516.2010.02348.x
  45. Tang L., Wu R., Sun J., Zhang X., Feng X., Zhang X., Luke K.-H., Poon M.-C., Short-term low-dose secondary prophylaxis for severe/moderate haemophilia A children is beneficial to reduce bleed and improve daily activity, but there are obstacle in its execution: a multi-centre pilot study in China, 10.1111/j.1365-2516.2012.02926.x
  46. Hacker M. R., Geraghty S., Manco-Johnson M., Barriers to compliance with prophylaxis therapy in haemophilia, 10.1046/j.1365-2516.2001.00534.x
  47. ISARANGKURA P., Haemophilia care in the developing world: benchmarking for excellence, 10.1046/j.1365-2516.2002.00600.x
  48. SKINNER MARK W., WFH: Closing the global gap - achieving optimal care : WFH: CLOSING THE GLOBAL GAP, 10.1111/j.1365-2516.2012.02822.x
  49. Srivastava Alok, You Steve K, Ayob Yasmin, Chuansumrit Ampaiwan, de Bosch Norma, Perez Bianco Raul, Ala Fereydoun, Hemophilia Treatment in Developing Countries: Products and Protocols, 10.1055/s-2005-922219
  50. Mannucci P. M., Evolution of the European guidelines for the clinical development of factor VIII products: little progress towards improved patient management, 10.1111/hae.12041
  51. DIMICHELE D. M., Ethical considerations in clinical investigation: exploring relevance in haemophilia research, 10.1111/j.1365-2516.2008.01738.x
  52. Emanuel Ezekiel J., Wendler David, Killen Jack, Grady Christine, What Makes Clinical Research in Developing Countries Ethical? The Benchmarks of Ethical Research, 10.1086/381709
  54. Ling M., Heysen J. P. H., Duncan E. M., Rodgers S. E., Lloyd J. V., High incidence of ankle arthropathy in mild and moderate haemophilia A : , 10.1160/th10-07-0492
  55. RODRIGUEZ-MERCHAN E. C., The haemophilic ankle, 10.1111/j.1365-2516.2006.01285.x
  56. Merchan, Acta Orthop Belg, 58, 122 (1992)
  57. QUEROL F., RODRIGUEZ-MERCHAN E. C., The role of ultrasonography in the diagnosis of the musculo-skeletal problems of haemophilia : THE ROLE OF US IN THE DIAGNOSIS OF MUSCULO-SKELETAL PROBLEMS OF HAEMOPHILIA, 10.1111/j.1365-2516.2011.02680.x
  58. Martin-Hervás Carmen, Rodríguez-Merchán Emérito-Carlos, Imaging of the Hemophilic Joint, Current and Future Issues in Hemophilia Care ISBN:9781119979401 p.121-126, 10.1002/9781119979401.ch24
  59. STEPHENSEN D., TAIT R. C., BRODIE N., COLLINS P., CHEAL R., KEELING D., MELTON K., DOLAN G., HAYE H., HAYMAN E., WINTER M., Changing patterns of bleeding in patients with severe haemophilia A, 10.1111/j.1365-2516.2008.01876.x
  60. Hilliard P., Zourikian N., Blanchette V., Chan A., Elliott B., Israels S. J., Nilson J., Poon M.-C., Laferriere N., Van Neste C., Jarock C., Wu J., McLimont M., Feldman B., Musculoskeletal health of subjects with hemophilia A treated with tailored prophylaxis: Canadian Hemophilia Primary Prophylaxis (CHPS) Study, 10.1111/jth.12113
  61. Löfqvist, Clin Orthop Relat Res, 343, 37 (1997)
  62. TSAILAS P. G., WIEDEL J. D., Arthrodesis of the ankle and subtalar joints in patients with haemophilic arthropathy : ARTHRODESIS OF THE ANKLE IN HAEMOPHILIA, 10.1111/j.1365-2516.2010.02248.x
  63. Rodriguez-Merchan E. Carlos, Orthopaedic Problems about the Ankle in Hemophilia, 10.1053/j.jfas.2012.06.005
  64. Lundgren P., Nester C., Liu A., Arndt A., Jones R., Stacoff A., Wolf P., Lundberg A., Invasive in vivo measurement of rear-, mid- and forefoot motion during walking, 10.1016/j.gaitpost.2007.10.009
  65. Massaad Firas, Lejeune Thierry M., Detrembleur Christine, The up and down bobbing of human walking: a compromise between muscle work and efficiency : Optimal centre of mass displacement of the body in human walking, 10.1113/jphysiol.2007.127969
  66. Lobet, ScientificWorldJournal, 284358 (2013)
  67. Inman, Arch Phys Med Rehabil, 48, 484 (1967)
  68. Lobet Sébastien, Hermans Cedric, Bastien Guillaume J., Massaad Firas, Detrembleur Christine, Impact of ankle osteoarthritis on the energetics and mechanics of gait: The case of hemophilic arthropathy, 10.1016/j.clinbiomech.2012.01.009
  69. Daniels Tim, Thomas Rhys, Etiology and Biomechanics of Ankle Arthritis, 10.1016/j.fcl.2008.05.002
  70. Egloff, Swiss Med Wkly, 142, w13583 (2012)
  71. Wynarsky George T., Greenwald A.Seth, Mathematical model of the human ankle joint, 10.1016/0021-9290(83)90132-x
  72. McKinley T.O., Tochigi Y., Rudert M.J., Brown T.D., The effect of incongruity and instability on contact stress directional gradients in human cadaveric ankles, 10.1016/j.joca.2008.04.005
  73. Valderrabano Victor, Nigg Benno M., von Tscharner Vinzenz, Stefanyshyn Darren J., Goepfert Beat, Hintermann Beat, Gait analysis in ankle osteoarthritis and total ankle replacement, 10.1016/j.clinbiomech.2007.05.003
  74. Valderrabano Victor, Horisberger Monika, Russell Iain, Dougall Hugh, Hintermann Beat, Etiology of Ankle Osteoarthritis, 10.1007/s11999-008-0543-6
  75. LOBET S., DETREMBLEUR C., LANTIN A.-C., HAENECOUR L., HERMANS C., Functional impact of custom-made foot orthoses in patients with haemophilic ankle arthropathy : FOOT ORTHOSES IN PATIENTS WITH HAEMOPHILIA, 10.1111/j.1365-2516.2011.02711.x
  76. Carlos Rodríguez-Merchán, Joint Surgery in the Adult Patient with Hemophilia (2014)
  77. DE LA CORTE-RODRIGUEZ H., RODRIGUEZ-MERCHAN E. C., JIMENEZ-YUSTE V., Radiosynovectomy in hemophilia: quantification of its effectiveness through the assessment of 10 articular parameters : Effectiveness of radiosynovectomy in hemophilia, 10.1111/j.1538-7836.2011.04246.x
  78. Rodriguez-Merchan E.C., De la Corte-Rodriguez H., Jimenez-Yuste V., Radiosynovectomy in haemophilia: Long-term results of 500 procedures performed in a 38-year period, 10.1016/j.thromres.2014.08.023
  79. Wallny Thomas, Brackmann Hans, Kraft Clayton, Nicolay Claudia, Pennekamp Peter, Achilles tendon lengthening for ankle equinus deformity in hemophiliacs: 23 patients followed for 1–24 years, 10.1080/17453670610045867
  80. van Meegeren M. E. R., van Vulpen L. F. D., Roosendaal G., Lafeber F. P. J. G., Mastbergen S. C., Joint distraction: a treatment to consider for haemophilic arthropathy, 10.1111/hae.12007
  81. Pearce, J Bone Joint Surg Br, 76, 947 (1994)
  82. Bluth B. E., Fong Y. J., Houman J. J., Silva M, Luck J. V., Ankle fusion in patients with haemophilia, 10.1111/hae.12114
  83. Bai Zhengwu, Zhang Enshui, He Yeteng, Yan Xinfeng, Sun Huaqiang, Zhang Ming, Arthroscopic Ankle Arthrodesis in Hemophilic Arthropathy, 10.1177/1071100713481775
  84. Barg, Haemophilia, 16, 647 (2010)
  85. Gadd Richard J., Barwick Thomas W., Paling Ellen, Davies Mark B., Blundell Chris M., Assessment of a Three-Grade Classification of Complications in Total Ankle Replacement, 10.1177/1071100714524549
  86. Bonasia, Iowa Orthop J, 30, 119 (2010)
  87. Henricson Anders, Nilsson Jan-Åke, Carlsson Åke, 10-year survival of total ankle arthroplasties : A report on 780 cases from the Swedish Ankle Register, 10.3109/17453674.2011.636678
  88. Bolton-Maggs Paula HB, Pasi K John, Haemophilias A and B, 10.1016/s0140-6736(03)13405-8
  89. Dalyan, Turk J Pediatr, 42, 205 (2000)
  90. Luck James V., Silva Mauricio, Rodriguez-Merchan Carlos E., Ghalambor Navid, Zahiri Christopher A., Finn Richard S., Hemophilic Arthropathy : , 10.5435/00124635-200407000-00004
  92. Gilbert, Semin Hematol, 30, 3 (1993)
  93. Pettersson, Clin Orthop Relat Res, 149, 153 (1980)
  94. Tusell J. M., Aznar J. A., Querol F., Quintana M., Moreno M., Gorina E., , Results of an orthopaedic survey in young patients with severe haemophilia in Spain, 10.1046/j.1351-8216.2001.00119.x
  95. Franchini Massimo, Coppola Antonio, Di Minno Giovanni, Di Minno Matteo, Ambrosino Pasquale, Arthropathy in Patients with Moderate Hemophilia A: A Systematic Review of the Literature, 10.1055/s-0033-1354422
  96. COLVIN B. T., ASTERMARK J., FISCHER K., GRINGERI A., LASSILA R., SCHRAMM W., THOMAS A., INGERSLEV J., , European principles of haemophilia care, 10.1111/j.1365-2516.2007.01625.x
  97. Cross Susan, Vaidya Sujit, Fotiadis Nicos, Hemophilic Arthropathy: A Review of Imaging and Staging, 10.1053/j.sult.2013.05.007
  98. DORIA A. S., State-of-the-art imaging techniques for the evaluation of haemophilic arthropathy: present and future : PRESENT AND FUTURE OF IMAGING OF HAEMOPHILIC ARTHROPATHY, 10.1111/j.1365-2516.2010.02307.x
  99. Lundin B., Babyn P., Doria A. S., Kilcoyne R., Ljung R., Miller S., Nuss R., Rivard G. E., Pettersson H., , Compatible scales for progressive and additive MRI assessments of haemophilic arthropathy, 10.1111/j.1365-2516.2005.01049.x
  100. OLIVIERI M., KURNIK K., PFLUGER T., BIDLINGMAIER C., Identification and long-term observation of early joint damage by magnetic resonance imaging in clinically asymptomatic joints in patients with haemophilia A or B despite prophylaxis : EARLIEST JOINT DAMAGE DETECTION BY MRI, 10.1111/j.1365-2516.2011.02682.x
  101. FUNK M. B., SCHMIDT H., BECKER S., ESCURIOLA C., KLARMANN D., KLINGEBIEL T., KREUZ W., Modified magnetic resonance imaging score compared with orthopaedic and radiological scores for the evaluation of haemophilic arthropathy, 10.1046/j.1365-2516.2002.00585.x
  102. Kilcoyne R. F., Nuss R., Radiological assessment of haemophilic arthropathy with emphasis on MRI findings, 10.1046/j.1365-2516.9.s1.11.x
  103. Ceponis A., Wong-Sefidan I., Glass C. S., von Drygalski A., Rapid musculoskeletal ultrasound for painful episodes in adult haemophilia patients, 10.1111/hae.12175
  104. Di Minno M. N. D., Iervolino S., Soscia E., Tosetto A., Coppola A., Schiavulli M., Marrone E., Ruosi C., Salvatore M., Di Minno G., Magnetic resonance imaging and ultrasound evaluation of “healthy” joints in young subjects with severe haemophilia A, 10.1111/hae.12107
  105. ZUKOTYNSKI K., JARRIN J., BABYN P. S., CARCAO M., PAZMINO-CANIZARES J., STAIN A. M., DORIA A. S., Sonography for assessment of haemophilic arthropathy in children: a systematic protocol, 10.1111/j.1365-2516.2006.01414.x
  106. Martinoli C., Della Casa Alberighi O., di Minno G., Graziano E., Molinari A. C., Pasta G., Russo G., Santagostino E., Tagliaferri A., Tagliafico A., Morfini M., Development and definition of a simplified scanning procedure and scoring method for Haemophilia Early Arthropathy Detection with Ultrasound (HEAD-US) : , 10.1160/th12-11-0874
  107. Jelbert A., Vaidya S., Fotiadis N., Imaging and staging of haemophilic arthropathy, 10.1016/j.crad.2009.07.005
  108. Srivastava A., Haemophilia care - beyond the treatment guidelines, 10.1111/hae.12429
  109. O'Mahony B et al An introduction to key concepts in health economics for haemophilia organisations 2010
  110. O'Mahony B et al Hemophilia Societies: Challenges and Development 2011
  111. EDQM Proceedings on the Optimal Use of Clotting Factors and Immunoglobulins
  112. EHC Meeting Report, Brussels 2013
  113. Giangrande, Blood Transfus, 12, s525 (2014)
  114. O'Mahony Brian, Kent Alastair, Aymé Ségolène, Pfizer-sponsored satellite symposium at the European Haemophilia Consortium (EHC) Congress : Changing the policy landscape: haemophilia patient involvement in healthcare decision-making, 10.1111/ejh.12316
  115. Noone, Haemophilia, 17, e842 (2011)
  116. Noone D., O'Mahony B., van Dijk J. P., Prihodova L., A survey of the outcome of prophylaxis, on-demand treatment or combined treatment in 18-35-year old men with severe haemophilia in six countries, 10.1111/j.1365-2516.2012.02934.x
  117. O'Mahony B., Noone D., Giangrande P. L. F., Prihodova L., Haemophilia care in Europe - a survey of 35 countries, 10.1111/hae.12125